Journal of Medical Economics
Volume 27, 2024 - Issue 1
Open access
453
Views
0
CrossRef citations to date
0
Altmetric
Oncology
Validation of overall survival extrapolations made by TLV in the assessment of cost-effectiveness of oncology drugs in Sweden – A pilot study comparing extrapolated and observed life-years gained
Jonas Björnerstedta Department of Economics, Södertörn University, Huddinge, Sweden
, Hannah Almqvistb Dental and Pharmaceutical Benefits Agency (TLV), Stockholm, Sweden
, Douglas Lundinb Dental and Pharmaceutical Benefits Agency (TLV), Stockholm, Sweden
& Niklas Zethraeusb Dental and Pharmaceutical Benefits Agency (TLV), Stockholm, Sweden;c Department of Learning, Informatics, Management and Ethics (LIME), Karolinska Institutet, Stockholm, SwedenCorrespondence[email protected]
https://orcid.org/0000-0003-4036-6966
https://orcid.org/0000-0003-4036-6966
Pages 193-200
|
Received 22 Dec 2023, Accepted 09 Jan 2024, Published online: 29 Jan 2024
Reprints and Permissions
Permission is granted subject to the terms of the License under which the work was published. Permission will be required if your reuse is not covered by the terms of the License.
To request a reprint or commercial or derivative permissions for this article, please click on the relevant link below.
For more information please visit our Permissions help page.
Related research
People also read lists articles that other readers of this article have read.
Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.
Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.